跳至主要内容
临床试验/NCT02122133
NCT02122133终止不适用

CARE: A Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400

Penumbra Inc.1 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Penumbra Inc.
入组人数
67
试验地点
1
主要终点
1. Acute radiation exposure [air kerma, kerma-area product (KAP) or dose area product (DAP), and fluoroscopic time].

研究概览

简要总结

The primary objective of this study is to gather data on the radiation exposure in patients treated with the Penumbra Coil 400™ System (PC 400) or conventional coils per their respective indications for use.This is a multicenter case review study of patients presenting with intracranial aneurysms who are treated with coil embolization therapy using the PC 400 or conventional coils. Data for each patient are collected acutely.Up to 90 patients treated with the PC 400 or conventional coils (2:1) at up to 15 centers in the USA will be enrolled.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients enrolled in the PC 400 arm must be those treated according to the cleared indication for the PC 400 System, which includes endovascular embolization of intracranial aneurysms.
  • Patients treated with conventional coils should be treated per their IFU.
  • Adjunctive use of stents, balloons or liquid embolics, if considered appropriate by investigators, is allowed.

排除标准

  • Pre-planned use of multiple coil systems and/or flow diverters.

结局指标

主要结局

1. Acute radiation exposure [air kerma, kerma-area product (KAP) or dose area product (DAP), and fluoroscopic time].

时间窗: At immediate post-procedure

Radiation exposure is measured by air kerma, kerma-area product (KAP) or dose area product (DAP), and fluoroscopic time.

2. Procedural serious adverse events

时间窗: Procedural serious adverse events up until 3 days or discharge, whichever occurs first.

次要结局

未报告次要终点

研究者

发起方
Penumbra Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验